The Omega Caro-E food supplement, developed by CPUT innovators, Prof Spinney Benade and Dr Maretha Opperman is being snatched up by consumers.
Introduced to the South African market earlier this year, sales have already reached the R300 000 mark.
And with a stamp of approval from the Cancer Association of South Africa (Cansa), monthly sales of the supplement have doubled.
“Since Cansa came on board, our sales soared to R 100 000 in April, and R 68 00 in May. All this was achieved without any advertising in the media,” says Benade.
In March the supplement received a Seal of Recognition from Cansa. This is the first time that the organisation has endorsed a food supplement.
Omega Caro-E, which is available in capsules, provides an affordable option to communities to lower the risk of developing chronic ailments like heart disease, arthritis, cancer, strokes and skin disorders.
CEO of Cansa, Sue Janse van Rensburg says the decision to support the product is based on extensive research and analysis of 64 fish oil supplements that are currently available on the market.
The research commissioned by Cansa found that the Omega Caro-E Supplement was unique and contained a diversity of natural molecules that may assist in reducing the risk of cancer.
“Accredited literature indicates that marine derived fish oil, plant derived carotenes as well as vitamin E may assist in reducing the risk from some chronic diseases like cancer. We therefore recognise Omega Caro-E as a first time Cansa Smart Choice Supplement,” says Janse van Rensburg.
The product is marketed by Cansa and is available for purchase at the organisation’s more than 50 offices, which are situated across the country.
The product retails at R97.
It is also available from the Functional Foods Unit at the Bellville Campus. To purchase the product or for more information please contact the unit at +27 (21) 953 8676/7.
Written by Candes Keating
Email:
Provides coverage for the Engineering and Applied Sciences Faculties; the Bellville and Wellington Campuses, and research and innovation news.